vdaka, dobre vediet, vyskum pokracuje dalej. chapem spravne ze v tejto studii pouzivali plazmu uzdravenych z covidu bez ohladu na to ci preukazatelne obsahovala protilatky?

“Pathak said these risks should be thoroughly investigated and considered when designing future clinical trials, that only plasma with detectable levels of antibodies should be given to participants to ensure that all patients can receive any possible benefit, that future trials should be double-blinded with sham procedure controls, and that non-immune plasma shouldn't be used for controls because of its potential harms and the availability of lower-risk interventions such as normal saline.”